WHO says mpox cases in Congo’s epicenter where the new variant was detected may be ‘plateauing’
November 11, 2024
Mpox cases in Congo’s South Kivu region are stabilizing, particularly where the latest infectious variant was first found among local workers in Kamituga. While this plateau is promising, WHO reports that infections continue rising in other regions and neighboring countries like Burundi and Uganda. Challenges persist with limited testing access, making it difficult to track the virus fully. About 50,000 people in Congo have been vaccinated, though the Africa CDC estimates 3 million doses are needed. Experts urge expanded vaccination to contain the virus, preventing it from reaching more densely populated areas or spreading internationally.
Recent data from the WHO shows promising signs of stability in mpox cases in Congo’s South Kivu region, where the more infectious variant was first detected among miners and sex workers in Kamituga. This stabilization, however, contrasts with the ongoing rise in cases across other parts of Congo, as well as in neighboring countries Burundi and Uganda. The WHO cautions that limited testing access continues to hinder a comprehensive understanding of mpox’s transmission dynamics, making effective containment a challenge.
In South Kivu, lab-confirmed cases have decreased from nearly 400 in July to under 100, with health experts optimistic that current containment efforts may prevent further spread. Nevertheless, Congo’s mpox response faces logistical obstacles; while 50,000 people have been vaccinated so far, the Africa CDC estimates at least 3 million doses are needed to curb the outbreak effectively.
The Africa CDC’s Director, Dr. Jean Kaseya, warned that without significant resources, the current outbreak could potentially transform into a global health crisis. In Burundi, where the variant continues spreading primarily among children and young adults, over 200 cases are reported weekly, raising additional public health concerns. In Uganda, where most cases are in adults, the virus has been spreading mainly through sexual transmission.
As mpox expands, the WHO has scheduled a November 22 meeting to assess if the outbreak still qualifies as a global health emergency. This recent spread beyond Africa, including cases in the UK linked to travel, emphasizes the importance of continued vigilance and international cooperation. Strengthened vaccination campaigns, particularly in high-risk areas, are vital to controlling mpox and preventing further transmission to densely populated regions and beyond.